Therapeutic effect of TSG-6 engineered iPSC-derived MSCs on experimental periodontitis in rats: A pilot study

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Yang, Heng ^a   Aprecio, Raydolfo M ^b   Zhou, Xiaodong ^b   Wang, Qi ^a   Zhang, Wu ^b   Ding, Yi ^c   Li, Yiming ^b  

^a SICHUAN UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY   (United States)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; CELL ADHESION MOLECULE; TNFAIP6 PROTEIN, RAT;

ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; EXPERIMENTAL DISEASE; FEMALE; FLOW CYTOMETRY; GENE; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PERIODONTITIS; PLURIPOTENT STEM CELL; PORPHYROMONAS GINGIVALIS; PROTEIN BLOOD LEVEL; RAT; STAINING; TUMOR NECROSIS FACTOR ALPHA STIMULATED GENE 6; ANIMAL; BACTEROIDACEAE INFECTIONS; BLOOD; CELL DIFFERENTIATION; CELL ENGINEERING; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; MAXILLA; MESENCHYMAL STROMA CELL; METABOLISM; MICROBIOLOGY; MOLAR TOOTH; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDACEAE INFECTIONS; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELL ENGINEERING; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; INDUCED PLURIPOTENT STEM CELLS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-1BETA; MAXILLA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MOLAR; OSTEOCLASTS; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903624808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100285     Document Type: Article

References (37)

1. Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal disease. Lancet 366:1809-1820.
2. Yilmaz S, Cakar G, Yildirim B, Sculean A (2010) Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J Clin Periodontol 37:544-550.
3. Emerton KB, Drapeau SJ, Prasad H, Rohrer M, Roffe P, et al. (2011) Regeneration of periodontal tissues in non-human primates with rhGDF-5 and beta-tricalcium phosphate. J Dent Res 90:1416-1421.
4. Stavropoulos A, Chiantella G, Costa D, Steigmann M, Windisch P, et al. (2011) Clinical and histologic evaluation of a granular bovine bone biomaterial used as an adjunct to GTR with a bioresorbable bovine pericardium collagen membrane in the treatment of intrabony defects. J Periodontol 82:462-470.
5. Tu YK, Needleman I, Chambrone L, Lu HK, Faggion CM Jr (2012) A Bayesian network meta-analysis on comparisons of enamel matrix derivatives, guided tissue regeneration and their combination therapies. J Clin Periodontol 39:303-314.
6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al Multilineage potential of adult human mesenchymal stem cells. (1999) Science 284:143-147.
7. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
8. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, et al. (2003) Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92:692-699.
9. Horwitz EM, Prockop DJ, Fitzpatripnck LA, Koo WWK, Gordon PL, et al. (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309-313.
10. Bianco P, Sacchetti B, Riminucci M (2011) Osteoprogenitors and the hematopoietic microenvironment. Best Pract Res Clin Haematol 24:37-47.
11. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, MacArthur BD, et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
12. Prockopl DJ, Oh JY (2012) Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. Mol Ther. 20:14-20.
13. Milner CM, Day AJ (2003) TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 116:1863-1873.
14. Wisniewski HG, Maier R, Lotz M, Lee S, Klampfer L, et al. (1993) TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis. J Immunol 151:6593-6601.
15. Bardos T, Kamath RV, Mikecz K, Glant TT (2001) Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor stimulated gene-6) in murine models of experimental arthritis. Am J Pathol 159:1711-1721.
16. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, et al. (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
17. Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, et al. (2011) Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells 29:1572-1579.
18. Mahoney DJ, Mikecz K, Ali T, Mabilleau G, Benayahu D, et al. (2008) TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation. J Biol Chem 283:25952-25962.
19. Mahoney DJ, Swales C, Athanasou NA, Bombardieri M, Pitzalis C, et al. (2011) TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with ostioprotegerin. Arthritis Rheum 63:1034-1043.
20. Katsara O, Mahaira LG, Iliopoulou EG, Moustaki A, Antsaklis A, et al. (2011) Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 20:1549-1561.
21. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
22. Meng X, Neises A, Su RJ, Payne KJ, Ritter L, et al. (2012) Efficient Reprogramming of Human Cord Blood CD34+ Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone. Mol Ther 20:408-416.
23. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S (2009) Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5:237-241.
24. Meng X, Baylink DJ, Sheng M, Wang H, Gridley DS, et al. (2012) Erythroid promoter confines FGF2 expression to the marrow after hematopoietic stem cell gene therapy and leads to enhanced endosteal bone formation. PLoS One 7:e37569.
25. Pontes Andersen CC, Buschard K, Flyvbjerg A, Stoltze K, Holmstrup P (2006) Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki rats. J Periodontol 77:350-356.
26. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321:1218-1221.
27. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, et al. (2008) Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118:507-17.
28. Furth ME, Atala A (2009) Stem cell sources to treat diabetes. J Cell Biochem 106:507-511.
29. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, et al. (2010) Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 121:1113-1123.
30. Villa-Diaz LG, Brown SE, Liu Y, Ross AM, Lahann J, et al. (2012) Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells 30:1174-1181.
31. de Hemptinne I, Vermeiren C, Maloteaux JM, Hermans E (2004) Induction of glial glutamate transporters in adult mesenchymal stem cells. J Neurochem 91:155-166.
32. Wisniewski HG, Hua JC, Poppers DM, Naime D, Vilcek J, et al. (1996) TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 156:1609-15.
33. Getting SJ, Mahoney DJ, Cao T, Rugg MS, Fries E, et al. (2002) The link module from human TSG-6 inhibits neutrophil migration in a hyaluronan- and inter-alpha -inhibitor-independent manner. J Biol Chem 277:51068-76.
34. Cao TV, La M, Getting SJ, Day AJ, Perretti M (2004) Inhibitory effects of TSG-6 Link module on leukocyte-endothelial cell interactions in vitro and in vivo. Microcirculation 11:615-24.
35. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kB signaling in resident macrophages. Blood 118:330-338.
36. Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
37. Chang M-Y, Kim D, Kim C-H, Kang H-C, Yang E, et al. (2010) Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One 5:e9838.